OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis
Jinhui Wang, Tingting Gao, Yijun Ma, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115181-115181
Closed Access | Times Cited: 5
Jinhui Wang, Tingting Gao, Yijun Ma, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115181-115181
Closed Access | Times Cited: 5
Showing 5 citing articles:
The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364
Yucheng Tian, Kang Liu, Dongdong Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116275-116275
Closed Access | Times Cited: 2
Yucheng Tian, Kang Liu, Dongdong Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116275-116275
Closed Access | Times Cited: 2
Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as selective ROCK2 inhibitors with anti-breast cancer migration and invasion activities
Zhi Cao, Xiujian Wei, Shuming Xing, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107675-107675
Closed Access | Times Cited: 1
Zhi Cao, Xiujian Wei, Shuming Xing, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107675-107675
Closed Access | Times Cited: 1
In Vitro Experiment Present ROCK2 Inhibition Promotes the Therapeutic of Bevacizumab in Treatment of Glioblastoma Multiforme
Jun Lai, Xiaojing Zhang, Kaixin Liang
Clinical Neuropharmacology (2024)
Closed Access | Times Cited: 1
Jun Lai, Xiaojing Zhang, Kaixin Liang
Clinical Neuropharmacology (2024)
Closed Access | Times Cited: 1
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity
Churu Mao, Jiebin Fang, Shijie Zou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20619-20638
Closed Access | Times Cited: 1
Churu Mao, Jiebin Fang, Shijie Zou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20619-20638
Closed Access | Times Cited: 1
Insight into Structure-Activity Relationship of New Compounds for Breast Cancer Treatment
Lu Li, Qiangsheng Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2373-2393
Closed Access | Times Cited: 1
Lu Li, Qiangsheng Zhang
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 25, pp. 2373-2393
Closed Access | Times Cited: 1
